Secondary outcomes
tumor, SD, deviationTumor
TUMOR, COMPLICATION, SECONDARY
At 3-months follow-up 13 out of 14 patients were alive and 1 patient in the LITT arm died after a complication. Median KPS worsened in both control and LITT group at 6 weeks and 3-months follow-up.All patients completed the online QoL questionnaire at screening and 12 out of 14 (86%, 3 in control group, 9 in LITT group) at 3-months follow-up. Patients in both groups showed a worse QLQ-BN20 Mean Total Score and lower EQ-5D Mean Index Value and Mean Visual Analogue Score.Eleven patients (78%, 3 in the control group and 8 in the LITT group) underwent a 3-month follow-up MRI. Mean tumor volume increased on 3-months post-operative MRI in both groups, both in T2 and T1 with contrast.An overview of the secondary outcomes is depicted in Table 
Summary of the secondary outcomes of the study. QLQ-BN20 Mean total score: higher scores represent worse quality of life. EQ-5D Mean Index Value: maximum score of 1 indicates the best health state. EQ-5D Visual Analogue Scale: maximum score of 100 indicates the best health state. LITT, laser interstitial thermal therapy; KPS, Karnofsky Performance Score. SD, standard deviationTumor volume T1 mlMean (SD)Tumor volume T2 mlMean (SD)